Brazilian stock alert
Afternoon Alert: Brazil Pharma keeps sliding: down 21.9% in 6 days 16 January 2018 12:10 BRST
NEWS BITES - BRIC
Brasil Pharma SA (SA:BPHA3) extended its slide on Tuesday, shedding an additional 15.0 centavos (or 4.8%) to trade at R$3.0. Trading volume was 1.8 times average so far today. The shares have fallen 84.0 centavos (or 21.9%) over the past six trading days vs. the Brazil Index 50 which has risen 0.8% in the same period.
SECTION 1: The past week
Current indications of bearish signals that support the trend in the unusual trading
1.1 At a glance
Weekly: Brazil Pharma continues significant downtrend January 15, 2018 18:00 BRST
Brasil Pharma SA (SA:BPHA3) has sunk 69.0 centavos (or 18.0%) in the past week to close at R$3.15. Compared with the Brazil Index 50 which rose 63.6 points (or 0.5%) in the week, this represented a relative price change of -18.4%. The volume was 1.5 times average trading per week of 498,375 shares. In the past week the market cap has slumped R$78 million.
1.2 5-day Recap
Brazil Pharma underperformed the Brazil index 50 in 5 out of 5 days.
|Day||Headline||Close price [BRL]||Price change %||Relative change %||Comment|
|Monday||Brazil Pharma keeps sliding, down 18.0% in 5 days||3.15||-1.6||-2.0|
|Friday||Brazil Pharma falls in 4 out of last 5 days||3.2||-4.5||-4.5|
|Thursday||Brazil Pharma continues significant downtrend; drops 3.7%||3.35||-3.7||-5.2|
|Wednesday||Brazil Pharma in its biggest weekly loss in 3 weeks||3.48||-4.7||-3.8||VI=3.3|
|Tuesday||Brazil Pharma down 35% in less than 14 weeks||3.65||-4.9||-4.6||Steepest Fall|
SECTION 2: Technical indicators
The negative 0.29 MACD (Moving Average Convergence Divergence) indicator suggests a bearish signal (12-day minus 26-day Exponential Moving Averages). Both the 12-day and the 26-day EMA are falling - another bearish signal. In the past week, the stock's MACD has been negative every day, a reinforcing bearish signal.
The stock has underperformed 97% of the Brazilian market over the past 6 months.
In the last one month the stock has hit a new 52-week low seven times and in the last three months ten times, pointing to a significant downtrend.
The price plummeted 17.8% in the last week and 22.7% in the last month.
The present value of BRL1,000 invested one year ago is R$536 [vs R$1,262 for the Brazil Index 50], for a capital loss of R$464. The total return to shareholders for 1 year is -46.4%.
The 1.0% premium to 12-month low of R$2.97 against the 70.7% discount to high of R$10.24 suggests the decline might be bottoming.
SECTION 3: Ranking
|Description||Value||Rank In Market|
|MCap $US million||105.5||In Bottom Quartile|
|52-week Range (in R$)||3.0-10.2|
|1-month Range (in R$)||3.0-4.2|
|Today's Volatility %||4.4||In Bottom Quartile|
|Price/MAP200||0.59||In Bottom 4%|
Brasil Pharma SA (SA:BPHA3; SAO:BPHA3; BZ:BPHA3)